Fetal Tissue Research (FTR)
Research using human fetal tissue or cell lines derived from human fetal tissue for therapeutic purposes shows much promise for treating serious diseases and disorders such as diabetes, sepsis, HIV/AIDS, spinal cord injuries, and neurodegenerative diseases.
University researchers may conduct research using human fetal tissue or cell lines derived from human fetal tissue ("human fetal tissue") for nontransplantation purposes only in accordance with applicable federal and state laws and regulations, as well as University policies and procedures.
Researchers who wish to conduct studies involving human fetal tissue must obtain approval from the Fetal Tissue Research (FTR) committee if the research does not meet the criteria for review by the Institutional Review Board (IRB).
The FTR committee reviews the scientific merit and ethical justification of proposed research involving human fetal tissue and cell lines derived from human fetal tissue and determines whether to approve, require modifications to, or disapprove the research.
Contact us for an application or for any amendments to approved applications.